Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Primus Partners Survey Reveals Optimistic Outlook for Viksit Bharat: Indians Express Confidence and 33 Experts Chart the Roadmap for Amrit Kaal
- Indian OTT: Global ambitions, regional stronghold; Govt announces Marathi OTT on the anvil
- E-Panchayat Portal Paves Way For New Age Panchayats In Chhattisgarh
- Common Security Hold Area at Airports Could Reduce Connection Times By 90%: Primus Partners